5-[[4-[(2,3-DiMethyl-2H-indazol-6-yl)aMino]-2-pyriMidinyl]aMino]-2-MethylbenzenesulfonaMide
| | 1252927-47-1 Basic information More.. |
| Product Name: | 5-[[4-[(2,3-DiMethyl-2H-indazol-6-yl)aMino]-2-pyriMidinyl]aMino]-2-MethylbenzenesulfonaMide | | Synonyms: | GSK-1071306;5-[[4-[(2,3-DiMethyl-2H-indazol-6-yl)aMino]-2-pyriMidinyl]aMino]-2-MethylbenzenesulfonaMide;Pazopanib Impurity 13;N-Demethyl Pazopanib;Pazopanib N-Desmethyl Impurity;Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)amino]-2-pyrimidinyl]amino]-2-methyl-;Pazopanib Impurity 41;5-[[4-[(2,3-dimethylindazol-6-yl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide | | CAS: | 1252927-47-1 | | MF: | C20H21N7O2S | | MW: | 423.49144 | | EINECS: | | | Mol File: | 1252927-47-1.mol |  |
Use
5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)amino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide is a Pazopanib (P210925) impurity. Pazopanib is an oral angiogenesis inhibitor targeting VEGFR and PDGFR.
|
|
1252927-47-1
Recommend Suppliers |
|
| Tag:
1252927-47-1
|